Navigation Links
HDS International Comments on Front-end Carbon Sequestration Technologies
Date:8/19/2011

PROVIDENCE, R.I., Aug. 19, 2011 /PRNewswire/ -- HDS International Corp. (OTCQB:  HDSI), a provider of industrial ocean-based biomass production and other high-value eco-sustainability solutions, today discussed the market opportunity associated with its carbon sequestration technologies.  

According to a previous report from Pike Research, a market research and consulting firm that provides in-depth analysis of global clean technology markets, under a base-case forecast scenario, global revenues for carbon capture and storage systems could reach $128 billion by 2030.  In a forecast scenario that includes more aggressive assumptions for global climate policy and industry adoption, the worldwide carbon capture and sequestration market could reach as high as $221 billion in the same timeframe.

HDS International believes that it is positioned at the forefront the carbon sequestration industries by virtue of its breakthrough carbon capture and fixation technologies.  While existing pathways for carbon sequestration include geological and chemical methods, these methods are often impractical and face significant secular limitations.

Geological sequestration faces limited storage capacity and the non-trivial scenario of an accidental high pressure leak or rock penetration.  Chemical sequestration is also problematic as it is expensive and the energy requirement to complete this process is enormous.  Biological sequestration, which includes the use of photosynthetic organisms such as algae to sequester CO2, offers the unique potential to overcome many of the hurdles faced by other sequestration methodologies and has emerged as a significant commercial opportunity.  

The HDS carbon biological fixation process employs a technological chain which allows us to, with minimal expenses, capture CO2 from the source of emission and deliver such CO2 to the point of biological growth in manageable condition—rele
'/>"/>

SOURCE HDS International Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. PAREXEL Named Company of the Year for the Pharmaceutical Industry in International Business Awards(SM)
2. Dyadic International Reports 2011 Second Quarter Financial Results
3. International Isotopes Inc. Announces Successful International Standards Certification for Manufacture of Its Nuclear Medicine Products and Devices
4. Dyadic International Announces Date of Second Quarter 2011 Financial Results Release and Conference Call
5. Roka Bioscience Participates in the International Association for Food Protection Conference
6. Daval International Announces Completion of Phase II Trial for the Treatment of Bladder Dysfunction With AIMSPRO® in Secondary Progressive Multiple Sclerosis
7. NAFG Announces Expanded International Surrogacy and Egg Donation Program
8. New Thriller Exposes International Bioterrorism Plot that Leaves the Human Race on the Brink of Certain Disaster
9. Cord Blood America CEO Matthew Schissler Interviewed on International Successes
10. International Isotopes Inc. Announces the Selection of Parsons as the Lead Design-Build Contractor for the Proposed Depleted Uranium De-Conversion Facility
11. Fiberstar Posts Strong Second Quarter Operating Results on Continued Rising International Demand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Fertility Associates of Memphis has announced a ... a network of more than 20 contributing fertility ... fast access to a national pool of frozen ... Associates of Memphis is the only fertility clinic in ... Dr. William Kutteh , director of Fertility Associates ...
(Date:12/19/2014)... -- Naurex Inc., a biopharmaceutical company leveraging its unique ... central nervous system, today announced that Norbert Riedel ... at the 33 rd annual J.P. Morgan Healthcare ... p.m. PST on Tuesday, January 13, 2015, at the ... About Naurex Inc. ...
(Date:12/19/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/fhh9rj/technology ) ... Innovations in Smart Fabrics (Technical Insights)" report ... http://photos.prnewswire.com/prnh/20130307/600769 The Research Service titled ... assessment on technological advancements and market for Smart ... 1. The Smart Fabrics market is expected to ...
(Date:12/19/2014)... Ed Bilsky, Ph.D., vice president for Research ... in the Neurosciences (CEN), and professor of pharmacology at ... a member of the prestigious Dana Alliance for Brain ... to receive this honor. , The Dana Alliance ... Dana Foundation. Its mission is to advance public ...
Breaking Biology Technology:Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2Technology Innovations in Smart Fabrics (Technical Insights) 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 3
... 14 at 8:00 a.m. PDT ... ... (Nasdaq: HALO ), a biopharmaceutical company developing and,commercializing products targeting the ... December 31, 2007., "Our achievements in 2007 have advanced our partnered ...
... (NASDAQ: ANPI , TSX: ANP), a global ... filing of its audited,consolidated financial statements and Management,s ... 2007 and the restatement of its audited,consolidated financial ... For the year ended December 31, 2007, ...
... CORONA, Calif., March 13 Watson,Pharmaceuticals, Inc. ... today confirmed that it has filed an Abbreviated ... Drug Administration (FDA) seeking,approval to market its Levonorgestrel ... oral contraceptive product prior to the,expiration of patents ...
Cached Biology Technology:Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 2Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 3Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 4Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 5Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 6Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 7Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results 8Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 2Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 3Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 4Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 5Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 6Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 7Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 8Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 9Watson Files FDA Application for Generic LYBREL(R) 2
(Date:12/19/2014)... Dec. 18, 2014   LaunchKey , the first ... post-password and Internet of Things era, today announced the ... venture round was led by Metamorphic Ventures with participation ... Partners, VegasTechFund, and others.  LaunchKey has raised $4 million ... expand its team and bring LaunchKey to market in ...
(Date:12/17/2014)... Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ... "Global Chemical Sensor Market 2015-2019" report to ... One major trend upcoming in ... sensors in biomedical applications. Chemical sensors help in ... diagnosis during surgical procedures. The Global Chemical Sensor ...
(Date:12/11/2014)... 10, 2014  That blood pressure plays a role in ... – the medical term for high blood pressure – was ... the inflatable cuff that,s used in measuring blood pressure was ... nothing new about hypertension, its triggers and its effects. In ... condition and the best ways to treat it. ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... preferred ingredient lists and consumer product guides appearing on ... the topic of the cover story in Chemical ... of the American Chemical Society, the world,s largest scientific ... Michael McCoy explains that cleaning products are at the ...
... ANN ARBORWorking beneath the towering oaks and maples on ... and their faculty adviser helped explain an observation that ... moth caterpillars. The caterpillars, which defoliate and sometimes ... the Northeast, are especially fond of oaks, but sugar ...
... of membranes, also known as phospholipids, are composed of two ... molecules form a bilayer in the membrane, with all of ... in a zip-like interlay position. Biomembranes are constantly ... is constantly creating new phospholipids that have to align themselves ...
Cached Biology News:Campus as laboratory: U-M student biologists use Diag trees to help solve gypsy moth mystery 2Campus as laboratory: U-M student biologists use Diag trees to help solve gypsy moth mystery 3Pathway for membrane building blocks 2
Kinase Buffer can be used to assay protein kinase activity...
Goat polyclonal to SPFH2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: EDEPLETATKEN, corresponding to C terminal amino acids 328-339 of Human SPFH2 Entrez Gene ID: 11...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
alpha/beta-Tubulin Antibody Ship: Hot Store: -20 C...
Biology Products: